CCL2 and COVID-19: Hyperinflammation associated with COVID-19 has been associated with increases in multiple cytokines, chemokines, and growth factors, including IL-1α, IL-1β, IL-6, IL-7, TNF-α, type I and II IFNs, CCL2, CCL3, and CXCL10 (25–27).